News

Media

Conferences

Publications

Clinical

Events

Resources

Subscribe

Peter Millin, PharmD Candidate

home / authors / peter-millin-pharmd-candidate

Articles

Rx Product News: Profile: A Closer Look at New FDA Actions: Nuvigil

This single, longer-acting R-enantiomer of the racemic modafinil has been approved as a wakefulness-promoting drug.

Read More

Editorial Staff

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.